MedShadow Blog

 

Who’s Responsible When a Generic Drug Kills?

April 25, 2017
Who’s Responsible When a Generic Drug Kills?

A loophole that allows generic drugmakers to avoid liability when patients experience side effects may be coming to an end thanks to a ruling in an antidepressant suicide lawsuit.

Why Drugs Should Take a Long Time to Get to Market

April 18, 2017
Why Drugs Should Take a Long Time to Get to Market

Drug companies, politicians and patient groups are clamoring for faster approval of drugs. But doing so could bring potentially harmful drugs to market.

Are Disease Advocacy Groups Industry Fronts?

April 11, 2017
Are Disease Advocacy Groups Industry Fronts?

A new study finds that many patient advocacy groups receive heavy funding from industry, creating a serious conflict of interest.

From Snip to Tear

April 5, 2017
From Snip to Tear

Episiotomies used to be a standard procedure with vaginal births. That’s changing as the procedure is seen as over-medicalization.

A Dose of Health Care for Haiti’s Poor

March 28, 2017
Catching Medicine Doing Good

A recent trip by the author to Haiti demonstrates that not-for-profits and drug companies can work together to benefit health care in poor countries.

Weighing Risks and Benefits on an FDA Advisory Committee

March 21, 2017
Weighing Risks and Benefits on an FDA Advisory Committee

More than 400 pages of medical research, 11 hours of testimony and a blizzard in March. Welcome to my first FDA Advisory hearing!

Lessons For the Future, From 60 Years Ago

March 7, 2017
Lessons For the Future, From 60 Years Ago

The tragedy of DES began 60 years ago as pregnant women took the synthetic estrogen that had dangerous side effects. But lessons have been learned.